SLU‑PP‑332 Non-peptide Lyophilized Powder C₂₄H₂₆N₂O₃
Molecular Formula: C₂₄H₂₆N₂O₃
Molecular Weight: 290.32 g/mol
Cas Number: 303760-60-3
Purity: 99.06% HPLC
Length: N/A – SLU‑PP‑332 contains zero amino acids — because it is not a peptide
Reconstitution Notice:
- Not always readily soluble with bacs water → sometimes requires an organic solvent (e.g: MPG, PEG300/400 or DMSO) before dilution
- Clear solution = properly dissolved; cloudiness/particles = not full solubility
- Use appropriate lab-grade sterile techniques and solvent compatibility for your assay system.
Type: synthetic small‑molecule PPAR‑δ agonist
COA (certificate of analysis) provided: SLU-PP-332 COA 99.06
Product Video:
SLU‑PP‑332 is a synthetic small‑molecule PPAR‑δ agonist, not a peptide, so it has a standard chemical structure rather than an amino‑acid sequence.
What SLU‑PP‑332 actually is
A potent PPAR‑δ activator
Designed to mimic some metabolic effects of exercise
Investigated for fat oxidation, endurance, mitochondrial function, and metabolic health
Structurally similar to other PPAR‑δ agonists (e.g., GW501516), but with different safety and activity profiles.
SLU‑PP‑332 is one of the more interesting “exercise‑mimetic” research compounds because it doesn’t behave like stimulants, peptides, or fat‑killers. It’s a small‑molecule PPAR‑δ agonist, designed to shift metabolism toward endurance‑style energy use.
Here’s what it actually does, in clear, biological terms.
What SLU‑PP‑332 Does
1. Activates PPAR‑δ (the endurance‑metabolism switch)
PPAR‑δ is a nuclear receptor that controls:
fat oxidation, mitochondrial efficiency, muscle fiber type (slow‑twitch vs fast‑twitch), glucose handling
SLU‑PP‑332 strongly activates this pathway, which is why it’s often described as an exercise‑mimetic.
2. Increases fat burning
By activating PPAR‑δ, SLU‑PP‑332 pushes the body toward:
higher fatty‑acid oxidation, lower fat storage, improved lipid metabolism
This is similar to the metabolic shift seen during long‑duration aerobic exercise.
3. Enhances endurance in research models
PPAR‑δ activation leads to:
more slow‑twitch, fatigue‑resistant muscle fibers
improved mitochondrial function
better energy efficiency
In animal studies, this produced significant endurance improvements even without training.
4. Improves glucose metabolism
PPAR‑δ activation supports:
better insulin sensitivity
improved glucose uptake
reduced metabolic inflammation
This is why it’s studied in metabolic syndrome and obesity models.
5. Not a stimulant
SLU‑PP‑332 does not:
raise heart rate
increase adrenaline
act on the CNS
Its effects are metabolic, not neurological.
How It Differs From Other Compounds
Not like AICAR (AMPK activator)
Not like GW501516 (similar pathway but different structure and safety profile)
Not like Adipotide (which kills fat‑cell vasculature)
Not a peptide (so no amino‑acid sequence)
Legal and Safety Information;
Quantum Peptides products are provided exclusively for laboratory research and educational use.
They are not approved for human or veterinary applications.
These materials are not intended to diagnose, treat, cure, or prevent any medical condition.
All use must adhere to applicable laws and regulatory requirements.
“The photo is for illustration purposes only and includes as much product information as possible. Bottle labels wrap around the container and may vary slightly in design & between batches as part of our anti‑counterfeiting measures.”


